Lymph node ratio should be considered for incorporation into staging for breast cancer

Annals of Surgical Oncology

Volumn 18, Issue 11, 2011, Pages 3143-3148

  Chagpar, Anees B ^a   Camp, Robert L ^a   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; CANCER GRADING; CANCER PATIENT; CANCER RISK; CANCER STAGING; CONFERENCE PAPER; CONTROLLED STUDY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PATHOLOGY; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 83055188236     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2012-9     Document Type: Conference Paper

References (21)

1. American Joint Committee on Cancer. Breast. In: Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging handbook. 7th ed. New York: Springer Verlag; 2010. p. 417-60.
2. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-75.
3. Saha S, Farrar WB, Young DC, Ferrara JJ, Burak WE Jr. Variation in axillary node dissection influences the degree of nodal involvement in breast cancer patients. J Surg Oncol. 2000;73:134-7.
4. Schaapveld M, Otter R, de Vries EG, et al. Variability in axillary lymph node dissection for breast cancer. J Surg Oncol. 2004;87:4-12.
5. Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:989-90.
6. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426-32.
7. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433-41.
8. Chagpar AB, Scoggins CR, Martin RC, et al. Factors determining adequacy of axillary node dissection in breast cancer patients. Breast J. 2007;13:233-7.
9. Axillary dissection. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ. 1998;158(Suppl 3): S22-6.
10. Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G. The lymph node ratio as prognostic factor in nodepositive breast cancer. Radiother Oncol. 2004;70:225-30.
11. Vinh-Hung V, Joseph SA, Coutty N, Ly BH, Vlastos G, Nguyen NP. Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer. Oncologist. 2010;15:1050-62.
12. van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol. 2002;28:481-9.
13. Truong PT, Lesperance M, Li KH, MacFarlane R, Speers CH, Chia S. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Ann Surg Oncol. 2010;17:2138-46.
14. Oven Ustaalioglu BB, Bilici A, Kefeli U, et al. Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences. Oncology. 2010;79:105-11.
15. Martinez-Ramos D, Escrig-Sos J, Alcalde-Sanchez M, Torrella-Ramos A, Salvador-Sanchis JL. Disease-free survival and prognostic significance of metastatic lymph node ratio in T1-T2N positive breast cancer patients. A population registry-based study in a European country. World J Surg. 2009;33:1659-64.
16. Ibrahim EM, Elkhodary TR, Zekri JM, et al. Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia. Asia Pac J Clin Oncol. 2010;6:130-7.
17. Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA Jr. Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1, 788 patients with long-term followup. J Am Coll Surg. 2010;210:797-805.
18. Chagpar AB, Scoggins CR, Martin RC, et al. Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol. 2007;14:670-7.
19. Chagpar AB, Scoggins CR, Martin RC, et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg. 2006;192:882-7.
20. Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005;190:543-50.
21. NCCN clinical practice guidelines in oncology: breast cancer. National Comprehensive Cancer Network. 2011. http://www.nccn.com/.